Quick Answer
BIOMARIN PHARMACEUTICAL INC reported Total Assets of $7.59 billion for fiscal year 2025.
BIOMARIN PHARMACEUTICAL INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $7.59B | +8.7% |
| 2024 | $6.99B | +2.2% |
| 2023 | $6.84B | +7.3% |
| 2022 | $6.38B | +6.2% |
| 2021 | $6.00B | +2.7% |
| 2020 | $5.85B | +24.7% |
| 2019 | $4.69B | +5.9% |
| 2018 | $4.43B | -4.4% |
| 2017 | $4.63B | +15.1% |
| 2016 | $4.02B | +7.9% |
| 2015 | $3.73B | +50.7% |
| 2014 | $2.48B | +10.3% |
| 2013 | $2.24B | +43.1% |
| 2012 | $1.57B | +20.1% |
| 2011 | $1.31B | +3.4% |
| 2010 | $1.26B | +37.7% |
| 2009 | $917.16M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.61B | +11.1% | +2.1% |
| June 30, 2025 | $7.46B | +5.5% | +4.3% |
| March 31, 2025 | $7.15B | +4.0% | +2.3% |
| December 31, 2024 | $6.99B | +2.2% | +2.0% |
| September 30, 2024 | $6.85B | +1.4% | -3.1% |
| June 30, 2024 | $7.07B | +7.7% | +2.8% |
| March 31, 2024 | $6.87B | +6.8% | +0.5% |
| December 31, 2023 | $6.84B | +7.3% | +1.2% |
- BIOMARIN PHARMACEUTICAL INC showed an increase of +8.7% in Total Assets compared to the prior fiscal year.
- Over the 2009–2025 period, BIOMARIN PHARMACEUTICAL INC’s total assets has grown by 728.0% (from $917.16 million to $7.59 billion).
- The most recent figure is from BIOMARIN PHARMACEUTICAL INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: